Interstitial pneumonitis induced by pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer

Med Oncol. 2012 Jun;29(2):1255-7. doi: 10.1007/s12032-011-9893-0. Epub 2011 Mar 10.

Abstract

Interstitial pneumonitis after treatment with pegylated liposomal doxorubicin (PLD) has been rarely reported. We describe herein a case of interstitial pneumonitis in a 49-year-old woman with relapsed ovarian carcinoma treated with PLD. Twenty-five days after the second administration of PLD, she presented with fever and dry cough, and chest CT scans revealed bilateral interstitial infiltrates and ground-glass opacities. She was diagnosed to have interstitial pneumonitis induced by PLD. Steroid therapy improved her symptoms.

Publication types

  • Case Reports

MeSH terms

  • Cystadenocarcinoma, Serous / drug therapy*
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives*
  • Female
  • Humans
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / drug therapy
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Staging
  • Ovarian Neoplasms / drug therapy*
  • Polyethylene Glycols / adverse effects*
  • Tomography, X-Ray Computed

Substances

  • liposomal doxorubicin
  • Polyethylene Glycols
  • Doxorubicin